> top > docs > PubMed:15116316 > annotations

PubMed:15116316 JSONTXT

Annnotations TAB JSON ListView MergeView

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-129 Sentence denotes Offspring gender ratio and the rate of recurrent spontaneous miscarriages in jewish women at high risk for breast/ovarian cancer.
TextSentencer_T2 130-221 Sentence denotes BRCA1/BRCA2 germline mutations are associated with an increased breast/ovarian cancer risk.
TextSentencer_T3 222-307 Sentence denotes Offspring gender ratios may be skewed against male births in BRCA1 mutation carriers.
TextSentencer_T4 308-459 Sentence denotes In addition, the lack of viable homozygous BRCA1/BRCA2-mutation carriers implies that recurrent miscarriages may be associated with homozygous fetuses.
TextSentencer_T5 460-676 Sentence denotes Jewish Israeli high-risk women who were tested for being carriers of the predominant BRCA1/BRCA2 mutations in Jewish high-risk families were analyzed for the sex of offspring and the rate of spontaneous miscarriages.
TextSentencer_T6 677-709 Sentence denotes Overall, 817 women participated:
TextSentencer_T7 710-840 Sentence denotes 393 BRCA1/BRCA2-mutation carriers (229 with breast/ovarian cancer) and 424 high-risk noncarriers (208 with breast/ovarian cancer).
TextSentencer_T8 841-931 Sentence denotes No differences between the male-to-female offspring ratios of all study groups were noted.
TextSentencer_T9 932-1007 Sentence denotes Among mutation carriers, the offspring male-to-female ratio was 0.97 (444 :
TextSentencer_T10 1008-1072 Sentence denotes 460), and among mutation carriers with cancer it was 0.92 (262 :
TextSentencer_T11 1073-1078 Sentence denotes 284).
TextSentencer_T12 1079-1185 Sentence denotes Similarly, no offspring gender skewing was noted among high-risk noncarriers, regardless of health status.
TextSentencer_T13 1186-1390 Sentence denotes The rates of three or more spontaneous miscarriages among participants with at least one live birth were 4.37% (15/343) among mutation carriers and 3% (12/401) among high-risk women (P = not significant).
TextSentencer_T14 1391-1503 Sentence denotes In conclusion, the offspring gender ratio is similar in high-risk Jewish families and in the general population.
TextSentencer_T15 1504-1592 Sentence denotes The issue of the rate of recurrent miscarriages in high-risk Jewish women is unresolved.
T1 0-129 Sentence denotes Offspring gender ratio and the rate of recurrent spontaneous miscarriages in jewish women at high risk for breast/ovarian cancer.
T2 130-221 Sentence denotes BRCA1/BRCA2 germline mutations are associated with an increased breast/ovarian cancer risk.
T3 222-307 Sentence denotes Offspring gender ratios may be skewed against male births in BRCA1 mutation carriers.
T4 308-459 Sentence denotes In addition, the lack of viable homozygous BRCA1/BRCA2-mutation carriers implies that recurrent miscarriages may be associated with homozygous fetuses.
T5 460-676 Sentence denotes Jewish Israeli high-risk women who were tested for being carriers of the predominant BRCA1/BRCA2 mutations in Jewish high-risk families were analyzed for the sex of offspring and the rate of spontaneous miscarriages.
T6 677-709 Sentence denotes Overall, 817 women participated:
T7 710-840 Sentence denotes 393 BRCA1/BRCA2-mutation carriers (229 with breast/ovarian cancer) and 424 high-risk noncarriers (208 with breast/ovarian cancer).
T8 841-931 Sentence denotes No differences between the male-to-female offspring ratios of all study groups were noted.
T9 932-1007 Sentence denotes Among mutation carriers, the offspring male-to-female ratio was 0.97 (444 :
T10 1008-1072 Sentence denotes 460), and among mutation carriers with cancer it was 0.92 (262 :
T11 1073-1078 Sentence denotes 284).
T12 1079-1185 Sentence denotes Similarly, no offspring gender skewing was noted among high-risk noncarriers, regardless of health status.
T13 1186-1390 Sentence denotes The rates of three or more spontaneous miscarriages among participants with at least one live birth were 4.37% (15/343) among mutation carriers and 3% (12/401) among high-risk women (P = not significant).
T14 1391-1503 Sentence denotes In conclusion, the offspring gender ratio is similar in high-risk Jewish families and in the general population.
T15 1504-1592 Sentence denotes The issue of the rate of recurrent miscarriages in high-risk Jewish women is unresolved.

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
15116316-5#37#42#gene672 714-719 gene672 denotes BRCA1
15116316-5#43#48#gene675 720-725 gene675 denotes BRCA2
15116316-5#147#161#diseaseC0029925 824-838 diseaseC0029925 denotes ovarian cancer
15116316-5#147#161#diseaseC1140680 824-838 diseaseC1140680 denotes ovarian cancer
15116316-5#84#98#diseaseC0029925 761-775 diseaseC0029925 denotes ovarian cancer
15116316-5#84#98#diseaseC1140680 761-775 diseaseC1140680 denotes ovarian cancer
15116316-5#147#161#diseaseC0029925 824-838 diseaseC0029925 denotes ovarian cancer
15116316-5#147#161#diseaseC1140680 824-838 diseaseC1140680 denotes ovarian cancer
37#42#gene672147#161#diseaseC0029925 15116316-5#37#42#gene672 15116316-5#147#161#diseaseC0029925 associated_with BRCA1,ovarian cancer
37#42#gene672147#161#diseaseC1140680 15116316-5#37#42#gene672 15116316-5#147#161#diseaseC1140680 associated_with BRCA1,ovarian cancer
37#42#gene67284#98#diseaseC0029925 15116316-5#37#42#gene672 15116316-5#84#98#diseaseC0029925 associated_with BRCA1,ovarian cancer
37#42#gene67284#98#diseaseC1140680 15116316-5#37#42#gene672 15116316-5#84#98#diseaseC1140680 associated_with BRCA1,ovarian cancer
37#42#gene672147#161#diseaseC0029925 15116316-5#37#42#gene672 15116316-5#147#161#diseaseC0029925 associated_with BRCA1,ovarian cancer
37#42#gene672147#161#diseaseC1140680 15116316-5#37#42#gene672 15116316-5#147#161#diseaseC1140680 associated_with BRCA1,ovarian cancer
43#48#gene675147#161#diseaseC0029925 15116316-5#43#48#gene675 15116316-5#147#161#diseaseC0029925 associated_with BRCA2,ovarian cancer
43#48#gene675147#161#diseaseC1140680 15116316-5#43#48#gene675 15116316-5#147#161#diseaseC1140680 associated_with BRCA2,ovarian cancer
43#48#gene67584#98#diseaseC0029925 15116316-5#43#48#gene675 15116316-5#84#98#diseaseC0029925 associated_with BRCA2,ovarian cancer
43#48#gene67584#98#diseaseC1140680 15116316-5#43#48#gene675 15116316-5#84#98#diseaseC1140680 associated_with BRCA2,ovarian cancer
43#48#gene675147#161#diseaseC0029925 15116316-5#43#48#gene675 15116316-5#147#161#diseaseC0029925 associated_with BRCA2,ovarian cancer
43#48#gene675147#161#diseaseC1140680 15116316-5#43#48#gene675 15116316-5#147#161#diseaseC1140680 associated_with BRCA2,ovarian cancer

DisGeNet-2017-sample

Id Subject Object Predicate Lexical cue
T1503 714-719 gene:672 denotes BRCA1
T1504 824-838 disease:C0029925 denotes ovarian cancer
T1505 720-725 gene:675 denotes BRCA2
T1506 761-775 disease:C0029925 denotes ovarian cancer
R1 T1503 T1504 associated_with BRCA1,ovarian cancer
R2 T1503 T1504 associated_with BRCA1,ovarian cancer
R3 T1505 T1506 associated_with BRCA2,ovarian cancer
R4 T1505 T1506 associated_with BRCA2,ovarian cancer
R5 T1505 T1504 associated_with BRCA2,ovarian cancer
R6 T1505 T1504 associated_with BRCA2,ovarian cancer

UBERON-AE

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 107-113 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T2 194-200 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T3 754-760 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T4 817-823 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 107-113 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T2 194-200 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T3 754-760 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T4 817-823 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast

DisGeNET

Id Subject Object Predicate Lexical cue
T0 720-725 gene:675 denotes BRCA2
T1 761-775 disease:C0029925 denotes ovarian cancer
T2 720-725 gene:675 denotes BRCA2
T3 761-775 disease:C1140680 denotes ovarian cancer
T4 720-725 gene:675 denotes BRCA2
T5 824-838 disease:C0029925 denotes ovarian cancer
T6 720-725 gene:675 denotes BRCA2
T7 824-838 disease:C1140680 denotes ovarian cancer
R1 T0 T1 associated_with BRCA2,ovarian cancer
R2 T2 T3 associated_with BRCA2,ovarian cancer
R3 T4 T5 associated_with BRCA2,ovarian cancer
R4 T6 T7 associated_with BRCA2,ovarian cancer